Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Distinguished Professor and Academic Tenure of Chemistry and also Enrico Fermi Distinguished Chair in Molecular Spectroscopy at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than five hundred reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI), Medline/PubMed and Scopus Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, New Zealand, Scotland, Ireland, Netherlands, Belgium, Denmark, Luxembourg, Romania, Greece, Russia, Estonia, Ukraine, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Indonesia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Kingdom of Saudi Arabia, Jordan, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than one thousand reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international and peer–reviewed journals, books and publishers. Hitherward, he is a member of more than five hundred reputed international academic–scientific–research institutes around the world. It should be noted that he is currently the President of the American International Standards Institute (AISI), Irvine, California, USA and also Head of Cancer Research Institute (CRI) and Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.

Biomedical scientist with 10+ years of experience in oncology with a strong background in exploiting
DNA damage response (DDR) and DNA repair pathways to develop small molecule cancer therapeutics.

Principal investigator on an independent grant ($225K).

Interdisciplinary collaborator with proven strong leadership, mentoring, and project management skills.

He completed his PhD in Biochemistry in 2013 from the University of Aveiro, a Master's in Biomolecular Methods in 2007 from the University of Aveiro and a Degree in Clinical Analysis and Public Health in 2004 from the Polytechnic Institute of Coimbra - School of Health Technology of Coimbra. He is an Adjunct Professor at the Polytechnic Institute of Coimbra - Coimbra Health School (IPC-ESTeSC) and Researcher at the University of Coimbra - Molecular Physics and Chemistry Research and Development Unit and at Labinsaúde - IPC-ESTeSC. He is currently the Coordinator of the Scientific-Pedagogical Unit of Biomedical Laboratory Sciences at ESTeSC, member of the School Council and member of the Technical-Scientific Council. Received 3 awards and/or honors. He works in the field of Medical and Health Sciences – Diagnostic and Therapeutic Technologies. He is co-editor of the Scientific Journal of the Academic Network of Health Sciences of Lusofonia – RevSALUS. He was a member of the Editorial Board and editor of the Portuguese Journal of Biomedical Sciences. Author and co-author of national and international publications, as well as oral communications and in poster form, with an index h=10. In his professional activities, he interacted with more than 50 collaborators in co-authorship of scientific works.

Dr. Ling Yin is currently an Academic Editor at Anhui Medical University and an Associate Professor at the Hefei Comprehensive National Science Center in China. She earned her PhD from South China Agricultural University in 2016 and has since conducted postdoctoral research at Fudan University and the University of Florida College of Medicine. Her research lies at the intersection of cancer immunology, gene therapy, and precision medicine, with a particular focus on multi-omics integration, AAV-based gene delivery systems, and immunomodulatory mechanisms in tumors and inflammatory diseases.

Dr. Yin has authored over 30 peer-reviewed publications in high-impact journals such as Drug Discovery Today, Frontiers in Immunology, Molecular Therapy, and Journal of Medical Virology. She serves as a reviewer for prestigious journals including Gut, Cell Reports Medicine, and Clinical and Translational Medicine, and holds editorial roles with Frontiers in Immunology, Global Translational Medicine, iNew Medicine, and IntechOpen. She has also served as a conference speaker, session chair, and committee member at numerous international scientific gatherings.

Her contributions to biomedical research have been recognized with several awards, including the Global Recognition Award (2024, 2026) and the High-Caliber Talent of Hefei City (2025). Dr. Yin is committed to advancing translational research that bridges molecular mechanisms and clinical applications.

Web of Science Researcher ID: LIC-3245-2024